Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
Condition(s):Spinocerebellar AtaxiaLast Updated:July 23, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Spinocerebellar AtaxiaLast Updated:July 23, 2013Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:April 8, 2016Completed
Condition(s):Heart FailureLast Updated:February 4, 2009Unknown status
Condition(s):ViremiaLast Updated:December 4, 2013Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:September 9, 2020Completed
Condition(s):Intravenous Immunoglobulin (IVIg) Therapy in a Home Infusion SettingLast Updated:August 7, 2019Terminated
Condition(s):CIDPLast Updated:February 15, 2023Completed
Condition(s):Critical Illness; Sepsis, SevereLast Updated:February 7, 2024Not yet recruiting
Condition(s):RabiesLast Updated:July 24, 2014Completed
Condition(s):Primary Immunodeficiency Diseases (PID); Immune Thrombocytopenic Purpura (ITP); Kawasaki SyndromeLast Updated:August 24, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.